Sector Alpha Week of 2026-07-29
Sector Alpha — machine-written from the numbers · Data as of 2026-07-29

BillionToOne, Inc.

BLLN
Healthcare · Diagnostics & Research

BillionToOne, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.

The price is between stages. Underneath, the last four quarters read improving. What settles it: the next one or two quarters of delivery.

Price
$134
P/E
170.4×
vs its own history
Revenue (Mar 26)
$0.1 B
+83.3% YoY
Profit (Mar 26)
$0.0 B
Operating margin
18.2%
+18.2 pp YoY
ROE
9%
FY25
ROIC
34.4%
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

BillionToOne, Inc. trades at $134, between stages. It sits at 100% of a 52-week range of $69 to $134. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 10 straight weeks.

Today the stock is between stages. At $134 it trades near its long-run average and sits at 100% of its 52-week range ($69–$134).

Jul 26: $134 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 1-year window.
week — of stage —
Price50-day avg
$139$120$101$82.7$63.9$$134Nov 25Jan 26Mar 26May 26Jul 26
$139$120$101$82.7$63.9$$134Nov 25Mar 26Jul 26
Beating or trailing, week by week since 2025 Each cell is one week from 2025 to now (39 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Nov 25Jul 26

Against the market, two honest reads. Cumulative: over the last 8 months the stock moved +34% while the S&P 500 moved +10% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 10 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

→ The trend is one thing; the bill is another. Are you paying up for it? Next: how the P/E reads against its own history.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

BillionToOne, Inc. trades at 170.4× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 170.4× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E
170.4×
too little history to rank
PEG
2.78
derived from 3-year earnings growth

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

BillionToOne, Inc. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 6 quarters across 1 curve, on partial evidence.

Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Where the trailing-twelve-month history is short, the curve falls back to single-quarter year-on-year growth — noisier, and the classifier smooths and caps base-effect spikes before reading. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from
Revenue
102%95%88%80%73%%83.3%Mar 24Mar 25Mar 26
102%95%88%80%73%%83.3%Mar 24Mar 25Mar 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
11%3.8%−3.0%−9.8%−17%%8.8%Mar 24Mar 25Mar 26
11%3.8%−3.0%−9.8%−17%%8.8%Mar 24Mar 25Mar 26
ROCE
Rising
latest 8.8% · span −14.8%–8.8%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Growth, year by year: revenue +106.7% in FY25, profit null Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoY
115%113%111%108%106%%106.7%FY23FY24FY25
115%113%111%108%106%%106.7%FY23FY24FY25
TTM growth by quarter Trailing-twelve-month growth versus the year-ago TTM, per quarter, %: revenue (left axis); profit and EPS (right axis).
Revenue TTM YoY
94%93%92%90%89%%89.5%Mar 24Mar 25Mar 26
94%93%92%90%89%%89.5%Mar 24Mar 25Mar 26
Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+106.7%
Revenue YoY (Mar 26)
+83.3%
latest quarter vs a year ago
Revenue 10y
110.4%
long-run compound pace

→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.

04 · 4-Factor Sector Score

4-Factor Sector Score

59.4/100 — rank 30 of 30 in Diagnostics & Research · 45% evidence confidence · provisional, ranked below fully-evidenced peers

BillionToOne, Inc. scores 59.4 out of 100 against the 30 companies it is compared with in Diagnostics & Research, ranking 30. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

The four contributions add to the total exactly: 26 + 14.4 + 9 + 10 = 59.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

BillionToOne, Inc. reported $0.1 B of revenue in the Mar 26 quarter, +83.3% year on year. That is the 5th straight quarter of year-on-year growth. Over 2 years it has compounded at 110.4% a year. The last full year, FY25, came in at $0.3 B. The last four reported quarters add to $0.4 B.

BillionToOne, Inc. reported $0.1 B of revenue in the Mar 26 quarter, +83.3% year on year. That is the 5th straight quarter of year-on-year growth. Over 2 years it has compounded at 110.4% a year. The last full year, FY25, came in at $0.3 B. The last four reported quarters add to $0.4 B.

FY25 revenue came in at $0.3 B (+106.7% on the year), capping 2 years at 110.4% compound. The latest quarter (Mar 26) printed $0.1 B, +83.3% year on year — the 5th consecutive quarter of year-over-year growth.

FY25 revenue $0.3 B (+106.7% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 3-year window. A bar is red when it is lower than the year before.
110.4% a year over 2 years
RevenueYoY growth
0.33115%0.25113%0.17111%0.08108%0.00106%$ B%$0B106.7%FY23FY24FY25
0.33115%0.25113%0.17111%0.08108%0.00106%$ B%$0B106.7%FY23FY24FY25
Mar 26: $0.1 B (+83.3% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
5th straight quarter of growth
Revenue (quarterly)YoY growth
0.12102%0.0995%0.0688%0.0380%0.0073%$ B%$0B83.3%Mar 24Mar 25Mar 26
0.12102%0.0995%0.0688%0.0380%0.0073%$ B%$0B83.3%Mar 24Mar 25Mar 26

Pace check: the last four quarters averaged +89.6% growth against the decade's 110.4% — the current year is running slower than its own long-run rate.

→ Revenue grew — did margins hold as it scaled? Next: 18.2% this quarter (+18.2 pp YoY).

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

BillionToOne, Inc.'s operating margin is 18.2% in the Mar 26 quarter, +18.2 percentage points against the same quarter a year ago. Across 3 fiscal years the operating margin has ranged −100.0% to 6.5%. The current quarter is running above every full year in that window.

BillionToOne, Inc.'s operating margin is 18.2% in the Mar 26 quarter, +18.2 percentage points against the same quarter a year ago. Across 3 fiscal years the operating margin has ranged −100.0% to 6.5%. The current quarter is running above every full year in that window.

The latest quarter's operating margin is 18.2%, +18.2 pp against the same quarter a year ago. Across 3 fiscal years the operating margin has ranged −100.0%–6.5%.

Why the margin moved: operating margin went +18.2 pp year on year while gross margin went +6.0 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

FY25: 6.5% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 3-year window.
within a −100.0–6.5% band over 3 years
operating marginYoY change (pp)
15%69%−16%61%−47%53%−78%45%−109%38%%%6.5%39.8%FY23FY24FY25
15%69%−16%61%−47%53%−78%45%−109%38%%%6.5%39.8%FY23FY24FY25
Mar 26: 18.2% operating margin (+18.2 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
22%39%7.4%33%−7.5%28%−22%22%−37%17%%%18.2%18.2%Mar 24Mar 25Mar 26
22%39%7.4%33%−7.5%28%−22%22%−37%17%%%18.2%18.2%Mar 24Mar 25Mar 26

→ Margins held — did that reach the bottom line? Next: profit null in the latest quarter.

07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

BillionToOne, Inc. earned $0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $0.0 B. That is 18.2% of the quarter's revenue. The same quarter a year earlier earned $0.0 B. 4 of the last 9 reported quarters were loss-making.

BillionToOne, Inc. earned $0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $0.0 B. That is 18.2% of the quarter's revenue. The same quarter a year earlier earned $0.0 B. 4 of the last 9 reported quarters were loss-making.

Mar 26 profit was $0.0 B, null year on year. On the full year, FY25 printed $0.0 B (null).

FY25 profit $0.0 B (null YoY) Net profit bars, $ B (left); YoY growth-% line (right). 3-year window. A bar is red when it is lower than the year before.
Net profit
0.02−0.01−0.03−0.05−0.08$ B$0BFY23FY24FY25
0.02−0.01−0.03−0.05−0.08$ B$0BFY23FY24FY25
Mar 26: $0.0 B (null YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)
0.020.010.00−0.01−0.02$ B$0BMar 24Mar 25Mar 26
0.020.010.00−0.01−0.02$ B$0BMar 24Mar 25Mar 26

→ Profit rose — but did the cash follow?

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

BillionToOne, Inc.'s cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $0.0 B of operating cash against $0.0 B of profit. After $0.0 B of capital spending, $0.0 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.

FY25: operating cash of $0.0 B against reported profit of $0.0 B, leaving free cash of $0.0 B after $0.0 B of capital spending.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO $0.0 B vs profit $0.0 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 3-year window, annual resolution.
Operating cashNet profitFree cash
0.030.00−0.03−0.05−0.08$ B$0B$0B$0BFY23FY24FY25
0.030.00−0.03−0.05−0.08$ B$0B$0B$0BFY23FY24FY25
Mar 26: operating cash $0.0 B = 100% of the quarter's profit Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 9 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
0.022101.2%0.014100.6%0.005100.0%−0.00499.4%−0.01298.8%$ B%$0B100%Mar 24Mar 25Mar 26
0.022101.2%0.014100.6%0.005100.0%−0.00499.4%−0.01298.8%$ B%$0B100%Mar 24Mar 25Mar 26

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

→ So follow the cash to where it goes. Next: $0.0 B of building over 3 years.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

BillionToOne, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $0.0 B over the last 3 fiscal years.

FY25: capex $0.0 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
0.0110.0080.0050.0030.000$ B$0BFY23FY24FY25
0.0110.0080.0050.0030.000$ B$0BFY23FY24FY25
Mar 26: capex $0.0 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 9 quarters.
Capex (quarterly)Free cash
1.20.0120.60.0060.00.000−0.6−0.006−1.2−0.012$ B$ B$0B$0BMar 24Mar 25Mar 26
1.20.0120.60.0060.00.000−0.6−0.006−1.2−0.012$ B$ B$0B$0BMar 24Mar 25Mar 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

→ Does all this activity actually earn its cost of capital? Next: ROE is 9%.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

BillionToOne, Inc. earns a ROE of 2% in FY25. That is up from a trough of −233% in FY23. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 3.2% net margin on 0.49× asset turns.

FY25 ROE is 2%, recovered from a FY23 trough of −233% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY25): 3.2% net margin × 0.49× asset turns × 1.31× balance-sheet leverage ≈ 2.1% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

FY25: ROE 2% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 3-year window, dips included.
the climb back from FY23's −233%
ROEROIC (annual)
36%−36%−109%−181%−253%%2.1%9.1%FY23FY24FY25
36%−36%−109%−181%−253%%2.1%9.1%FY23FY24FY25
Mar 26: ROIC 17.9% (TTM) Trailing-twelve-month ROIC and ROE, per quarter, %. Last 9 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)
21%11%1.3%−8.2%−18%%17.9%5.6%Sep 23Mar 25Mar 26
21%11%1.3%−8.2%−18%%17.9%5.6%Sep 23Mar 25Mar 26

→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.29.

11 · Dividend

Dividend

BillionToOne, Inc. pays no dividend. Across the last 9 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.

BillionToOne, Inc. does not currently pay a dividend. Across the last 9 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.

→ No payout to follow. The cash question becomes what the business does with what it earns instead.

12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

BillionToOne, Inc. carries total debt of $0.1 B against shareholder equity of $0.5 B as of Mar 26, a debt-to-equity of 0.27 — effectively unlevered. On the annual view that ratio went from 5.00 in FY23 to 0.23 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of $0.1 B against shareholder equity of $0.5 B — a debt-to-equity of 0.27. On the annual view, debt-to-equity went from 5.00 (FY23) to 0.23 (FY25). The returns on this page are earned, not borrowed.

FY25: debt $0.1 B at 0.23× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 3-year window.
Total debtDebt-to-equity
0.165.4×0.123.9×0.082.3×0.040.7×0.00−0.9×$ B×$0B0.23×FY23FY24FY25
0.165.4×0.123.9×0.082.3×0.040.7×0.00−0.9×$ B×$0B0.23×FY23FY24FY25
Mar 26: debt $0.1 B, debt-to-equity 0.27 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 9 quarters.
Total debt (quarterly)Debt-to-equity
0.165.4×0.123.9×0.082.3×0.040.7×0.00−0.9×$ B×$0B0.27×Sep 23Mar 25Mar 26
0.165.4×0.123.9×0.082.3×0.040.7×0.00−0.9×$ B×$0B0.27×Sep 23Mar 25Mar 26

→ Who owns this, and are they adding or leaving? Next: short interest is 10.0% of the float.

13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

10.0% of BillionToOne, Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 3.2 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 10.0% of the float is sold short, and at typical trading volumes it would take about 3.2 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
10.0%
of the tradable float
Days to cover
3.2
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

→ One last check: does the safety math agree? Next: the balance-sheet safety line.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

BillionToOne, Inc.: the Z-score reads 13.69. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

Why it matters: a Z-score of 13.69 sits well clear of the distress zone — the balance sheet is not the risk here.

The safety line in one sentence: the Z-score reads 13.69.

Related companies · same industry · Diagnostics & Research Every company is compared on the shape of its own curves, not static ratios. The Revenue, EPS and ROCE columns each draw that company's last 12 quarters as a mini line of the ACTUAL level (trailing-twelve-month revenue and EPS, and the ROCE itself) — so a line that climbs is a business getting bigger, a line that sinks is one shrinking. The colour tracks the same line: green when it is rising or steadily healthy, amber when it is rolling over from a high (still elevated but turning down), red when it is falling, grey when flat or stuck. Colour and direction always agree — a green line never points down. The ROCE curve is the return on capital (annual readings for peers, so a slightly coarser line than the quarterly one at the top of this page). The Stage column then runs the same 12-quarter trajectory classifier used at the top of the page on each company and names where it sits. What lands a company in each bucket: CONSISTENT — growth stays positive across the window and returns are healthy (ROCE ≥ 15%, or ROE ≥ 12% for lenders); IMPROVING — profit or EPS fell into real decline, bottomed a few quarters back, and has climbed back to positive and held there; TURNING AROUND — the same kind of trough but more recent, with the latest quarters just lifting off it (an early, unconfirmed turn); TOPPING OUT — growth is still positive but decelerating hard from its own peak while returns have stopped rising; DETERIORATING — two or more growth curves are shrinking (latest below zero) and staying there, not one soft quarter; MIXED — the curves genuinely disagree, or no clean majority, so no single word fits; NO READ — fewer than eight usable quarters. It is a like-for-like read of every company against its own past, not a ranking against the group.
CompanyP/EMkt capRevenueEPSROCEStage
BillionToOne, Inc. this page170.4×$6BNo read
Thermo Fisher Scientific Inc.30.1×$214BMixed
Danaher Corporation35.0×$140BImproving
IDEXX Laboratories, Inc.41.9×$45BConsistent
IQVIA Holdings Inc.30.1×$41BMixed
Agilent Technologies, Inc.28.2×$40BMixed
Waters Corporation55.7×$38BMixed
Natera, Inc.$36BNo read
Illumina, Inc.35.0×$29BNo read
Mettler-Toledo International Inc.32.6×$28BMixed
Quest Diagnostics Incorporated25.1×$26BMixed
Labcorp Holdings Inc.27.8×$26BMixed
Guardant Health, Inc.$19BNo read
Medpace Holdings, Inc.33.5×$16BMixed
ICON Public Limited Company81.3×$14BDeteriorating
Revvity, Inc.51.7×$12BDeteriorating
Charles River Laboratories International, Inc.$12BDeteriorating
Qiagen N.V.21.8×$9BImproving
Twist Bioscience Corporation$6BNo read
Sotera Health Company43.5×$5BMixed
RadNet, Inc.$5BMixed
Veracyte, Inc.51.5×$4BNo read
Adaptive Biotechnologies Corporation$4BNo read
GRAIL, Inc.$3BNo read
CareDx, Inc.$2BNo read
GeneDx Holdings Corp.$2BNo read
NeoGenomics, Inc.$2BNo read
Personalis, Inc.$1BNo read
OPKO Health, Inc.$1BNo read
Castle Biosciences, Inc.$1BNo read
Fulgent Genetics, Inc.$1BNo read
Myriad Genetics, Inc.$1BNo read
Biodesix, Inc.$0BNo read
Insight Molecular Diagnostics Inc.$0BNo read
Exagen Inc.$0BNo read
Burning Rock Biotech Limited$0BNo read
12 · Frequently asked questions

Frequently asked questions

What is BillionToOne, Inc.'s stock price today?

BillionToOne, Inc. trades at $134. The company is valued at $6.0 B. The stock sits at 100% of its 52-week range of $69–$134. Against the S&P 500 it has been ahead on a trailing-13-week view for 10 weeks. — as of 29 July 2026.

What were BillionToOne, Inc.'s latest quarterly results?

BillionToOne, Inc. reported revenue of $0.1 B and net profit of $0.0 B for the Mar 26 quarter. Earnings per share were $0.34. The operating margin was 18.2%, 18.2 pp higher than a year earlier. — as of 29 July 2026.

What is BillionToOne, Inc.'s revenue?

BillionToOne, Inc. reported revenue of $0.1 B in the Mar 26 quarter, +83.3% year on year. For the full FY25 fiscal year, revenue was $0.3 B (+106.7%). Over the last 2 years revenue compounded at 110.4% a year. — as of 29 July 2026.

What is BillionToOne, Inc.'s profit?

BillionToOne, Inc. earned $0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $0.0 B. The operating margin ran 18.2% in the latest quarter. — as of 29 July 2026.

What is BillionToOne, Inc.'s market cap?

BillionToOne, Inc.'s market capitalisation is $6.0 B at a stock price of $134. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 29 July 2026.

Does BillionToOne, Inc. pay a dividend?

No — BillionToOne, Inc. has declared no dividend per share in any of its last 9 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 29 July 2026.

How is BillionToOne, Inc. performing?

BillionToOne, Inc.'s latest readings are below. Against the S&P 500 it has been ahead on a trailing-13-week view for 10 weeks. This describes what the data did, not a rating. — as of 29 July 2026.

Is BillionToOne, Inc. beating the market?

On recent form, yes — BillionToOne, Inc. has been ahead of the S&P 500 on a trailing-13-week view for 10 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 8 months the stock moved +34% against the S&P 500's +10% — ahead of the index over the full window. — as of 29 July 2026.

Will BillionToOne, Inc.'s stock price go up?

This page publishes no price forecast for BillionToOne, Inc. What it measures instead: the stock price is $134. Direction is not something this site claims to know. — as of 29 July 2026.

Is the market betting against BillionToOne, Inc.?

Somewhat — short interest is 10.0% of BillionToOne, Inc.'s tradable float, about 3.2 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 29 July 2026.

Does BillionToOne, Inc. have too much debt?

No — BillionToOne, Inc.'s debt-to-equity is 0.29. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. The returns on this page are earned, not borrowed — as of 29 July 2026.

What is BillionToOne, Inc.'s capex?

BillionToOne, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.0 B. — as of 29 July 2026.

What is BillionToOne, Inc.'s cash flow?

BillionToOne, Inc. generated $0.0 B of operating cash flow in FY25 and $0.0 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $0.0 B, so operating cash ran ahead of profit. — as of 29 July 2026.

How financially safe is BillionToOne, Inc.?

On the balance sheet, the Z-score reads 13.69 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 29 July 2026.

Where is BillionToOne, Inc. in its business cycle?

BillionToOne, Inc.'s FY25 operating margin was 6.5%, against a 3-year band of −100.0%–6.5%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 18.2%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 29 July 2026.

What could break the BillionToOne, Inc. story?

Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 29 July 2026.

Is BillionToOne, Inc. a stock worth studying right now?

This is not investment advice. The machine read: BillionToOne, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 29 July 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI